Mamatha Racheruvu, MBBS

Mamatha Racheruvu practices at Premier Dialysis - Plano Dexter in Birmingham, Alabama.

Mamatha Racheruvu's NPI, 1548573587, was assigned on July 20, 2010. Mamatha Racheruvu graduated from Osmania Medical College NTR UHS in 2007. Mamatha Racheruvu holds Texas license Q3579.

Mamatha Racheruvu's primary practice is Premier Dialysis - Plano Dexter, at 117 Gemini Cir, Birmingham, AL 35209 in Jefferson County. The practice phone is (469) 596-7020.

Mamatha Racheruvu's primary practice is Premier Dialysis - Plano Dexter in Birmingham, Alabama. Mamatha Racheruvu is also affiliated with Medical City Plano Hospital. The medical group on file is Dallas Renal Group. Dmand AI also links Mamatha Racheruvu to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mamatha Racheruvu practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Mamatha Racheruvu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Mamatha Racheruvu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Mamatha Racheruvu's licenses on file in 3 states: Texas, Alabama and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, gout, hypercalcemia, kidney cysts and parathyroid gland disorder among the conditions Mamatha Racheruvu treats.

CMS data shows 2,417 Medicare services from Mamatha Racheruvu across 12 procedure codes in 2024, for 356 Medicare patients. Medicare paid $154,598 for them.

CMS counts 356 Medicare patients who saw Mamatha Racheruvu in 2024. The largest group is 75 to 84, with 146 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mamatha Racheruvu's median patient age at 71, with 46% women.

In 2024, Mamatha Racheruvu wrote 1,311 Medicare Part D claims for 267 patients. 88% of them were for generic drugs. CMS names the drug for 1,100 of them, across 27 drugs with 11 or more claims each, at $166,844 in total drug cost. In 2023, CMS named 799 claims across 22 drugs.

Mamatha Racheruvu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mamatha Racheruvu as offering telehealth.

CMS Open Payments shows 121 general payments to Mamatha Racheruvu from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $546.

Mamatha Racheruvu graduated from Osmania Medical College NTR UHS in 2007.

Mamatha Racheruvu is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.